American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3
复制标题
DOI：
10.1002/art.41596
复制
发表时间：
2020-12-05
影响因子：
13.3
通讯作者：
Saag, Kenneth G.
中科院分区：
文献类型：
--
作者：
Mikuls, Ted R.;Johnson, Sindhu R.;Saag, Kenneth G.
目的在2019冠状病毒病（COVID-19）大流行的背景下，为风湿病提供者提供成人风湿病管理的指导。方法召集了一个由10名风湿病学家和4名来自北美的传染病专家组成的工作组。对临床问题进行了整理，并迅速生成和传播了证据报告。采用改良的德尔菲法对问题和声明草案进行审查和评估。这包括通过电子邮件进行异步匿名投票，以及与整个小组进行网络研讨会。工作队成员采用1-9分的数字评分系统对是否同意声明草案进行投票，根据投票的分散程度将共识分为低、中或高。为了获得批准，需要中位票数以达到预定义的一致水平（中值7-9、4-6和1-3定义为一致、不确定或不一致，）结果工作组批准的指南声明草案已合并为最终指南。结论提供这些指南声明以促进当前期间的最佳护理流行病然而，鉴于现有证据水平低和文献发展迅速，本指南作为“活文件”提出，预计未来会更新。
Objective To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID-19) pandemic.Methods A task force, including 10 rheumatologists and 4 infectious disease specialists from North America, was convened. Clinical questions were collated, and an evidence report was rapidly generated and disseminated. Questions and drafted statements were reviewed and assessed using a modified Delphi process. This included asynchronous anonymous voting by email and webinars with the entire panel. Task force members voted on agreement with draft statements using a 1-9-point numerical scoring system, and consensus was determined to be low, moderate, or high based on the dispersion of votes. For approval, median votes were required to meet predefined levels of agreement (median values of 7-9, 4-6, and 1-3 defined as agreement, uncertainty, or disagreement, respectively) with either moderate or high levels of consensus.Results Draft guidance statements approved by the task force have been combined to form final guidance.Conclusion These guidance statements are provided to promote optimal care during the current pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a "living document," and future updates are anticipated.